The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Comparing the cost-effectiveness and safety of additional low-dose glucocorticoid in
treatment strategies for elderly patients with rheumatoid arthritis:
The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (GLORIA)